The Treatment of Psoriasis with 0.1% Domoprednate (a D-Homocorticosteroid) and 0.1% Betamethasone Valerate Ointment

Jørgen V. Christiansen,Erik K. Foged,Per Holm,A.S. Jørgensen,Flemming Reymann

The Treatment of Psoriasis with 0.1% Domoprednate (a D-Homocorticosteroid) and 0.1% Betamethasone Valerate Ointment

1985

Jørgen V. Christiansen
Erik K. Foged
Per Holm
A.S. Jørgensen
Flemming Reymann

In 85 patients with psoriasis vulgaris the efficacy and tolerance of domoprednate and betamethasone valerate were studied in a double-blind, randomized trial lasting 4 weeks. Complete or satisfactory

Keywords:

Dermatology
Psoriasis
Randomized controlled trial
Domoprednate
Chemotherapy
Statistical significance
Medicine
Betamethasone valerate
double blind study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations